Id |
Subject |
Object |
Predicate |
Lexical cue |
T561 |
342-350 |
PATO_0000694 |
denotes |
advanced |
T756 |
342-364 |
PM2069 |
denotes |
advanced breast cancer |
T562 |
390-400 |
PATO_0001046 |
denotes |
resistance |
T563 |
413-417 |
CHEBI_23888 |
denotes |
drug |
T564 |
663-672 |
CHEBI_16469 |
denotes |
estradiol |
T565 |
663-672 |
CHEBI_23965 |
denotes |
estradiol |
T566 |
841-851 |
CHEBI_35610 |
denotes |
cytostatic |
T567 |
852-865 |
PATO_0000033 |
denotes |
concentration |
T568 |
895-902 |
CHEBI_17263 |
denotes |
estrone |
T569 |
932-935 |
CHEBI_16234 |
denotes |
OH- |
T570 |
961-964 |
CHEBI_16234 |
denotes |
OH- |
T571 |
993-1000 |
CHEBI_27974 |
denotes |
estriol |
T572 |
1072-1080 |
CHEBI_50114 |
denotes |
estrogen |
T573 |
1129-1137 |
CHEBI_50114 |
denotes |
estrogen |
T574 |
1238-1251 |
PATO_0002102 |
denotes |
proliferative |
T575 |
1359-1367 |
PATO_0000297 |
denotes |
arrested |
T576 |
1390-1395 |
PATO_0000083 |
denotes |
phase |
T577 |
1805-1812 |
PATO_0000393 |
denotes |
maximal |
T578 |
1824-1837 |
PATO_0000033 |
denotes |
concentration |
T579 |
1917-1920 |
CHEBI_16234 |
denotes |
OH- |
T580 |
1928-1931 |
CHEBI_16234 |
denotes |
OH- |
T581 |
2061-2064 |
CHEBI_16234 |
denotes |
OH- |
T582 |
2071-2074 |
CHEBI_16234 |
denotes |
OH- |
T583 |
2088-2091 |
CHEBI_16234 |
denotes |
OH- |
T586 |
2197-2206 |
PATO_0000470 |
denotes |
increased |
T584 |
2209-2212 |
CHEBI_16234 |
denotes |
OH- |
T585 |
2286-2289 |
CHEBI_16234 |
denotes |
OH- |
T587 |
2370-2378 |
PATO_0000463 |
denotes |
distinct |
T588 |
2388-2399 |
PATO_0000025 |
denotes |
composition |
T589 |
2435-2443 |
CHEBI_50114 |
denotes |
estrogen |